Clinical trialNCT05204459RecruitingObservational

MS-ResearchBiomarkerS

SponsorCedars-Sinai Medical CenterEnrollment1,000Clinically Isolated SyndromeHealthy AgingMultiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive+5 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brooke Guerrero, MD
Cedars-Sinai Medical Center
Study Director
clinicaltrials.gov ↗
Laura Locke, CRNP
Cedars-Sinai Medical Center
Study Director
clinicaltrials.gov ↗
Marwa Kaisey, MD
Cedars-Sinai Medical Center
Study Director
clinicaltrials.gov ↗
Nancy Sicotte, MD
Cedars-Sinai Medical Center
Study Chair
clinicaltrials.gov ↗
Omar Al-Louzi, MD
Cedars-Sinai Medical Center
Principal Investigator
clinicaltrials.gov ↗
Pascal Sati, PhD
Cedars-Sinai Medical Center
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Cedars-Sinai Medical Center
Los Angeles, California, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Nov 2021
Primary completion: 11 Nov 2041
Completion: 11 Nov 2041
Last update posted: 6 Feb 2024
Registered enrollment: 1,000
Registry id: NCT05204459

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.